News

GlaxoSmithKline has received the European Commission authorization for Synflorix, a pediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle

According to Emisphere, the Eligen technology is a unique and improved delivery method for therapeutic molecules and nutritional supplements. The key benefit of Eligen technology is that it

According to Bioject, the new Zetajet system is the latest advance in needle-free delivery systems, offering a significant array of unique product features and patient benefits that can

Mr Khiang is a co-founder, partner and director of multiple investment companies, including Evia Capital Partners and Evia Growth Opportunities since 2004, and has been a director of

Sinobiopharma is reportedly the world’s first manufacturer and marketer of Perindopril in capsule form. The company’s patent application covers the method of preparation and stability for new drug

Under the terms of the collaboration, Millennium will pay a $4 million upfront fee for an exclusive antibody-drug conjugate (ADC) license to an initial antigen expressed on solid

Bristol-Myers Squibb and AstraZeneca have reported that the FDA’s endocrinologic and metabolic drugs advisory committee determined that the data supporting the new drug application for Onglyza for the

Preclinical studies of CryoLife’s BioFoam surgical matrix, a protein hydrogel product under development for organ sealing, are nearing completion. This grant will help fund upcoming clinical studies of

Dr Kirchrath was most recently European pharmaceutical district manager for Affymetrix where he developed targeted sales and business development strategies, and managed cross-functional workflows between sales, marketing, field